Strep A vaccine partnership raises hope for millions
Griffith University will partner with a Chinese pharmaceutical for a new vaccine that has enormous potential to help millions. Clinical trials of the new, needle-free vaccine is targeted at Streptococcus A infection, the cause of strep throat and rheumatic heart disease and many other illnesses.